Patients with cardiac diseases or conditions with high risk of developing cardiac diseases
undergo risk assessment by cardiologists, primary care physicians, and scientists based on …

Risk stratification scheme. Risk stratification aiming at assessing the risk of VAs and SCD in
patients with MVP, involving two phases based on the clinical and imaging context and the …

Aims Clinical practice guidelines restrict rhythm control therapy to patients with symptomatic
atrial fibrillation (AF). The EAST-AFNET 4 trial demonstrated that early, systematic rhythm …

BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Background: Mitral valve prolapse (MVP) is a frequent disease that can be complicated by
mitral regurgitation (MR), heart failure, arterial embolism, rhythm disorders, and death. Left …

There is an increasing proportion of the general population surviving to old age with
significant chronic disease, multi-morbidity, and disability. The prevalence of pre-frail state …

Background and objective Atrial fibrillation (AF) is the most common form of cardiac rhythm
disorder. Early detection of AF can result in a lower risk of stroke, heart failure, systemic …

Atrial high rate episodes (AHREs) are defined as asymptomatic atrial tachyarrhythmias
detected by cardiac implantable electronic devices with atrial sensing, providing automated …

Mitral valve prolapse (MVP) is the most frequent valve condition but remains a conundrum in
many aspects, particularly in regard to the existence and frequency of an arrhythmic form …

Atrial fibrillation (AF) and heart failure (HF) are frequently associated and can be caused or
exacerbated by each other through different mechanisms. AF is particularly common in …